INBXInhibrx Biosciences, Inc.
$95.10+245% 1Y
$95.10
$27.1252 weeks$141.84
Is the price fair?
What INBX's price assumes
Inhibrx Biosciences, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 806× revenue.
806
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 816
EV / sales
Details›
- EV / salesas of 2026-Q1
- 816
- Market capitalisation
- $1.40B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry